| The 5th. DXA QA and The 1st Peripheral Densitometry Workshop |
|
|
|
|
|
|
|
| 2005-October
19th. Shangri-la Hangzhou, China |
|
|
|
|
|
|
|
| Scientific
Program |
|
|
|
|
|
|
|
| Time |
Description |
Speakers |
Translators |
Moderators |
|
|
|
|
|
|
| 830-900 |
Opening Ceremony and
Introduction |
John Shepherd |
Wei Yu |
Jinxue Lee |
|
|
|
|
|
|
|
|
Jianwe Ma |
|
|
|
|
|
|
|
|
|
|
Harry Genant |
Wei Yu |
|
|
|
|
|
|
|
| 900-930 |
1. Clinical Guidelines from
international agencies on the use of Densitometry techniques |
Harry Genant |
Xiaoguang Cheng |
Yanling Zhao |
|
|
|
|
|
|
| 930-1000 |
2. National quality assurance programs Differences and
Commonalities |
Xiaoguang Chen |
|
|
|
|
|
|
|
|
| 1000-1030 |
3. Measurement
and use of precision in densitometry |
Ying Lu |
|
|
|
|
|
|
|
|
| 1030-1045 |
Tea Break |
|
|
|
|
|
|
|
|
|
| 1045-1120 |
4. Quality assurance for x-ray devices |
John Shepherd |
Wei Yu |
Sheng Wu |
|
|
|
|
|
|
| 1120-1200 |
5. Quality assurance for QUS devices |
Didier Hans |
Xiaoguang Cheng |
|
|
|
|
|
|
|
| 1200-1300 |
Lunch |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The 1st Peripheral
Densitometry Course: QUS and DXA |
|
|
|
|
|
|
|
|
|
| 1300-1345 |
A. Intro to
Osteoporosis |
Wei Yu |
|
Ying Lu |
|
|
|
|
|
|
|
Definition of osteoporosis,
Pathophysiology of osteoporosis , Epidemiology of osteoporosis in China and
worldwide, Current diagnostic criteria, Common treatments |
|
|
|
|
|
|
|
|
|
| 1345-1415 |
6. Uniformity of T-and Z-scores across manufactueres for
Asian populations |
Akira Itabashi |
Xiaoguang Cheng |
|
|
|
|
|
|
|
| 1415-1445 |
B.
Technology for Peripheral Densitometry: Ultrasound based |
Chun Wu |
|
|
|
|
|
|
|
|
|
Axial versus transversal,dry versus wet,
fixed vs moving transducers, measurement sites, QUS parameters and their
respective sensitivities, factors influencing the precision, adults versus
children |
|
|
|
|
|
|
|
|
|
| 1445-1515 |
Tea Break |
|
|
|
|
|
|
|
|
|
| 1515-1545 |
C.
Technology for Peripheral Densitometry: X-ray based |
Sheng Wu |
|
Xiaoguang Chen |
|
|
|
|
|
|
|
Dose considerations,
Contrast of central DXA to peripheral x-ray measures, Measurement sites |
|
|
|
|
|
|
|
|
|
| 1545-1630 |
D.
Diagnosis and its Relationship to Fracture Risk and Treatment Threshold |
John Shepherd |
Wei Yu |
|
|
|
|
|
|
|
|
Guidelines for use, Study
review of Fracture risk data and peripheries. Monitoring change in bone
quality, Screening strategies |
|
|
|
|
|
|
|
|
|
| 1630-1715 |
E. Clinical Experience with
Peripheral Densitometry in Asia - 45 minutes |
|
|
|
|
|
|
|
|
|
|
This session covers the
clinical experience where users of peripheral densitometry tell of their
experience using their peripheral device including potential speakers from
Compumed, Hologic, Lunar, Alara, Sunlight, DMS, Alara, or other companies
working directly using peripheral devices for mass screening. |
|
|
|
|
|
|
|
|
|
| 1715-1745 |
F. The
Future Trends and Controversies |
Didier Hans |
Xiaoguang Cheng |
|
|
|
|
|
|
|
| 1745-1815 |
Closing remarks and EXAM |
|
Xiaoguang Cheng |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sponsors |
GE-Medical |
|
|
|
|
|
|
|
|
|
|
Hologic |
|
|
|
|
|
|
|
|
|
|
Sunlight |
|
|
|
|
|
|
|
|
|
|
DMS |
|
|
|
|
|
|
|
|
|
|
Compumed |
|
|
|
|
|
|
|
|
|
|
Synarc |
|
|
|
|
|
|
|
|
|
|
HOMA - Healthstar |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|